BR112015011931A2 - composições nutricionais contendo treonato de magnésio e usos das mesmas - Google Patents

composições nutricionais contendo treonato de magnésio e usos das mesmas

Info

Publication number
BR112015011931A2
BR112015011931A2 BR112015011931A BR112015011931A BR112015011931A2 BR 112015011931 A2 BR112015011931 A2 BR 112015011931A2 BR 112015011931 A BR112015011931 A BR 112015011931A BR 112015011931 A BR112015011931 A BR 112015011931A BR 112015011931 A2 BR112015011931 A2 BR 112015011931A2
Authority
BR
Brazil
Prior art keywords
magnesium threonate
nutritional compositions
compositions containing
containing magnesium
description
Prior art date
Application number
BR112015011931A
Other languages
English (en)
Inventor
Berg Brian
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49887325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015011931(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of BR112015011931A2 publication Critical patent/BR112015011931A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

resumo patente de invenção: "composições nutricionais contendo treonato de magnésio e usos das mesmas". a presente invenção refere-se à descrição da(s) composição(ões) nutricional(is) compreendendo uma fonte de carboidrato, uma fonte de proteína, uma fonte de gordura e treonato de magnésio. o treonato de magnésio pode fornecer os benefícios da saúde neurológica quando consumido. a descrição também se refere aos métodos de promoção da saúde neurológica fornecendo uma composição nutricional compreendendo treonato de magnésio. adicionalmente, a descrição se refere aos métodos de promoção da tolerância gi em um paciente pediátrico fornecendo uma composição nutricional compreendendo treonato de magnésio. 1/1
BR112015011931A 2013-01-11 2013-12-12 composições nutricionais contendo treonato de magnésio e usos das mesmas BR112015011931A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/739,813 US9301966B2 (en) 2013-01-11 2013-01-11 Nutritional compositions containing magnesium threonate and uses thereof
PCT/US2013/074539 WO2014109863A1 (en) 2013-01-11 2013-12-12 Nutritional compositions containing magnesium threonate and uses thereof

Publications (1)

Publication Number Publication Date
BR112015011931A2 true BR112015011931A2 (pt) 2017-07-11

Family

ID=49887325

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015011931A BR112015011931A2 (pt) 2013-01-11 2013-12-12 composições nutricionais contendo treonato de magnésio e usos das mesmas

Country Status (18)

Country Link
US (1) US9301966B2 (pt)
EP (1) EP2943081B1 (pt)
CN (2) CN104883911A (pt)
AU (1) AU2013372899B2 (pt)
BR (1) BR112015011931A2 (pt)
CA (1) CA2897776A1 (pt)
EC (1) ECSP15034601A (pt)
ES (1) ES2649715T3 (pt)
HK (1) HK1214091A1 (pt)
MX (1) MX366527B (pt)
MY (1) MY170033A (pt)
NO (1) NO2967044T3 (pt)
PE (1) PE20151806A1 (pt)
PH (1) PH12015501688A1 (pt)
PL (1) PL2943081T3 (pt)
RU (1) RU2015122495A (pt)
SG (1) SG11201503753XA (pt)
WO (1) WO2014109863A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US10525016B2 (en) * 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
ES2971165T3 (es) * 2015-12-14 2024-06-03 Nestle Sa Composición nutricional y preparado para lactantes para estimular la mielinización de novo
CN106333366A (zh) * 2016-09-28 2017-01-18 张家港威胜生物医药有限公司 一种具有抗疲劳作用的组合物及其制备方法与用途
US11633486B2 (en) 2017-04-17 2023-04-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use
CN109845877B (zh) * 2017-11-30 2022-07-12 内蒙古伊利实业集团股份有限公司 一种水解蛋白脱苦组合物及其产品、制备和应用
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2022157798A1 (en) * 2021-01-22 2022-07-28 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for treating neurocognitive disorders
CN115868628B (zh) * 2022-10-11 2024-01-26 泓博元生命科技（深圳）有限公司 减肥组合物
CN115894216A (zh) * 2022-12-19 2023-04-04 浦拉司科技（上海）有限责任公司 一种l-苏糖酸镁的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143901A (zh) 2007-03-22 2021-07-23 纽罗森特里亚股份有限公司 镁组合物及其用途
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
WO2010047581A1 (en) * 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition
EP2251031A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
CN102573496B (zh) * 2009-07-01 2015-08-26 玛格塞蒂克斯公司 缓释镁组合物及其用途
US8648036B2 (en) 2010-12-29 2014-02-11 Mead Johnson Nutrition Company Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
ECSP15034601A (es) 2015-11-30
PE20151806A1 (es) 2015-12-17
NO2967044T3 (pt) 2018-06-02
MX2015008583A (es) 2015-09-04
PH12015501688B1 (en) 2015-10-19
PH12015501688A1 (en) 2015-10-19
RU2015122495A (ru) 2017-02-17
US20140200176A1 (en) 2014-07-17
WO2014109863A1 (en) 2014-07-17
CN110101079A (zh) 2019-08-09
SG11201503753XA (en) 2015-06-29
PL2943081T3 (pl) 2018-03-30
CN104883911A (zh) 2015-09-02
EP2943081A1 (en) 2015-11-18
MY170033A (en) 2019-06-26
ES2649715T3 (es) 2018-01-15
MX366527B (es) 2019-07-12
EP2943081B1 (en) 2017-10-04
CA2897776A1 (en) 2014-07-17
US9301966B2 (en) 2016-04-05
AU2013372899A1 (en) 2015-05-28
HK1214091A1 (zh) 2016-07-22
AU2013372899B2 (en) 2016-12-08

Similar Documents

Publication Publication Date Title
BR112015011931A2 (pt) composições nutricionais contendo treonato de magnésio e usos das mesmas
BR112015014800A2 (pt) derivados da exendina-4 funcionalizada
BR112015021888A2 (pt) inibidores de dna-ik
BR112016029906A2 (pt) compostos excipientes redutores de viscosidade para formulações proteicas
CR20150448A (es) Pirimidinas fusionadas sustituidas con trifluorometilo y sus usos
BR112014000268A2 (pt) pirazolopiridinas com substituinte heteroarilo e utilização destas
BR112013024199A2 (pt) métodos para melhorar a saúde óssea em bebês usando prebióticos
BR112014003640A2 (pt) métodos para perda de peso e composições cetogênicas
BR112014009225A8 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
BR112013017314A2 (pt) composições compreendendo inibidores de cotransportadores 1 e 2 de sódio-glicose e métodos de usos
PH12019500799A1 (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
BR112013026573A2 (pt) fórmula de lactente para uso na prevenção de doenças cardiovasculares
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
MY175195A (en) Nutritional compositions
BR112015005933A2 (pt) composição nutricional para mulher grávida com um perfil benéfico de glicose e insulina
EA201791611A1 (ru) Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида
DOP2016000076A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
BR112015018421A2 (pt) composição nutricional anti-regurgitação
BR112015022849A2 (pt) sais de adição de base de nitroxolina e usos dos mesmos
BR112015017432A2 (pt) métodos para o tratamento de indicações cardiovasculares
BR112015017546A2 (pt) composições hemostáticas, usos das mesmas e kit
BR112014016423A8 (pt) composição de controle de doença de planta
BR112015005904A2 (pt) composições contendo ácido beta-hidroxi-beta-metilbutírico e uso das mesmas
BR112015021781A2 (pt) alta dose única de mva induz uma resposta imune protetora em neonatos e lactentes
BR112014016890A8 (pt) composição para controle de doenças de plantas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]